Cooper Companies (NASDAQ:COO – Get Free Report) is projected to issue its quarterly earnings data after the market closes on Thursday, March 6th. Analysts expect the company to announce earnings of $0.92 per share and revenue of $981.25 million for the quarter. Cooper Companies has set its FY25 guidance at $3.92-$4.02 EPS and its FY 2025 guidance at 3.920-4.020 EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.
Cooper Companies (NASDAQ:COO – Get Free Report) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the previous year, the business earned $0.87 EPS. The company’s revenue was up 9.8% on a year-over-year basis. On average, analysts expect Cooper Companies to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.
Cooper Companies Trading Up 0.8 %
Shares of NASDAQ COO opened at $90.97 on Thursday. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $18.16 billion, a PE ratio of 46.65, a PEG ratio of 2.25 and a beta of 1.00. The business has a 50-day moving average price of $92.75 and a two-hundred day moving average price of $99.55. Cooper Companies has a one year low of $84.76 and a one year high of $112.38.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on Cooper Companies
Cooper Companies Company Profile
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Featured Stories
- Five stocks we like better than Cooper Companies
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Buffett’s on the Sidelines – Should You Follow?
- Stock Analyst Ratings and Canadian Analyst Ratings
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- 3 Warren Buffett Stocks to Buy Now
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.